Forty-two of these regions are novel, meaning that they have never before been implicated in the disease. The findings, published in Nature Genetics, bring new knowledge of the biological mechanisms at play and open up new avenues for treatment and d
The drug losartan, normally used to treat high blood pressure or hypertension does not effect in slowing down the progression of Alzheimer s disease (AD) in people with the mild-to-moderate disease after 12 months of treatment, suggests new research by the University of Bristol.
According to new research by the University of Bristol the drug losartan, normally used to treat high blood pressure or hypertension does not effect in slowing down the progression of Alzheimer s disease (AD) in people with the mild-to-moderate disease after 12 months of treatment.